Assender J and Leadbeater W. “Embedding research into the curriculum: Evaluating the impact on employability and progression to postgradaute study for BME and first generation university students” Higher Education Pedagogies
Assender J (2019)“Writing Retreat Days support part-time students with dissertation writing” Poster- Advance HE STEM conference
Assender J and Leadbeater W (2017) “Transitions in BSc Biomedical science students’ identify and career aspirations” Ignite Session: Higher Education Academy Annual Conference
Assender J and Leadbeater W (2016) “The trials and triumphs of embedding employability into the first year BSc Medical Sciences curriculum” Lightning Session: University of Birmingham Teaching and Learning Conference
Assender J and Leadbeater W (2016) “The trials and triumphs of embedding employability into the first year BSc Medical Sciences curriculum” Poster: Higher Education Academy Conference
Assender J, Tucker O and Belbin M (2013) “An inverted classroom blended learning module works well for postgraduate students”- Oral Presentation: University of Birmingham Teaching and Learning conference
Assender J (2004) “Does peer and self assessment add value to, and enliven, a poster session following a practical class?” Teaching Bioscience- Enhancing Learning Guide 1 “Self and Peer Assessment”, additional online case studies. Publisher: Centre for Biosciences, The Higher Education Academy.
Assender JW and Woodgate LJ (2001) “Medical practical classes for the 21st Century: An idea”. Biochem Soc Trans 29 (5) A135: 102
Assender JW, Gee JMW, Lewis I, Ellis IO, Robinson JFR, Nicholson RI (2007). Protein kinase C Isoform Expression as a Predictor of Disease Outcome on Endocrine Therapy in Breast Cancer” J Clinical Pathology: 60 (11) p1216-21.
Fredholm, BB, Assender JW, Irenius E, Kodama N, Saito N (2003) “Synergistic effects of adenosine A1 and P2Y receptor stimulation on Calcium mobilization and PKC translocation in DDT1 MF-2 cells” Cell. Mol. Neurobiol.: 23 (3) p370-400.
Hussain S, Assender JW, Bond M, Wong LF, Murphy D, Newby AC. (2002) “Activation of protein kinase-Cζ is essential for cytokine-induced metalloproteinase-1,-3 and 9 secretion from rabbit smooth muscle cells and inhibits proliferation.” J Biol Chem: 277(30) p27345-52.
Harper ME, Goddard L, Glynne-Jones E, Assender J, Dutkowski CM, Barrow D, Dewhurst OL, Wakeling AE, Nicholson RI (2002) “Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.” Prostate: 52(1) p59-68.
Assender JW, Irenius E, Fredholm BB (1997) “5-HT, Angiotensin and Bradykinin transiently increase [Ca2+i] and PKC-α activity but not mitogenesis in human vascular smooth muscle cells.” Acta Phys. Scanda.: 160, p207-17.
Assender JW, Irenius E, Fredholm BB (1996) "Endotehlin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells". Acta Physiol Scand 157: 451-60.
Assender JW, Kontny E and Fredholm BB (1994) “Expression of protein kinase C isoforms in smooth muscle cells in various states of differentiation” FEBs Letters 342 76-80.
Newby AC, Assender JW, Evans MA, Lim K, Bennett MR, Evan GI. (1994) “Transduction pathways for growth stimulatory and inhibitory actions of vasoactive agents”. Exp Nephrol 2: 94-100.
JW Assender,KM Southgate, MB Hallett, AC Newby (1992). Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth muscle cells. Biochem J: 288,527-532.
AC Newby, KM Southgate, JW Assender (1992). Inhibition of vascular smooth muscle cell proliferation by endothelium dependent vasodilators. Herz: 17,1-7.
Science Conference Presentations
E. Phillips and J. Assender (2017) “Tamoxifen Resistance: A Proteomic Approach” New Zealand Society of Oncology Conference
Shawcross E, Martin A and Assender JW(2008) “Proteomic profiling of Tamoxifen resistant MCF-7 cells”. Poster: British Association of Cancer Research Conference.
JW Assender and I Lewis (2007) “Up regulation of PKC-α and δ in tamoxifen resistant breast cancer – a role in insulin like growth factor stimulated cell proliferation”. Poster: Life Sciences 2007
I. Lewis,JW Assenderand RI Nicholson (2004) “Do Protein kinase C isoforms play a role in acquisition of resistance to anti-oestrogenic therapies in breast cancer” Poster: Keystone Symposia: Protein kinases and Cancer: The promise of molecular based therapies.
Hall SK,Assender JW.(2001) "Mitogen-activated protein kinase pathway mediates volume regulation in embryonic chick cardiac myocytes" Journal of Physiology: 536.P; 106P.
Assender JW, Dutkowski CM, Nicholson RI (2000). “IGF-1 induced increase in PKC-δ and PI-3-kinase activity are on different signalling pathways in breast cancer cells”. Poster: Signal Transduction 2000, Luxembourg.
Assender JW,Chapman J, Hall, S. (2000) “Mitogen-activated protein kinase mediates cell volume regulation”. Poster: IUBMB meeting, Birmingham.
Assender JW, Dutkowski CM, Nicholson RI (1997). “PKC isoform expression changes with endocrine responsiveness in breast cancer cell lines”. Poster: Nottingham 5th International Breast Cancer Symposium.
Assender JW, Irenius E, Fredholm BB. (1995) “Protein kinase C isoform expression and ATP response changes with smooth muscle cell differentiation”. Biochem Soc Trans (654th meeting): 453S.
View all publications in research portal